# Plasmonic Nanophotothermal Therapy of Atherosclerosis

> **NCT01270139** · NA · COMPLETED · sponsor: **Ural State Medical University** · enrollment: 180 (actual)

## Conditions studied

- Stable Angina
- Heart Failure
- Atherosclerosis
- Multivessel Coronary Artery Disease

## Interventions

- **PROCEDURE:** Transplantation of nanoparticles
- **PROCEDURE:** Transplantation of iron-bearing nanoparticles
- **DEVICE:** Stenting

## Key facts

- **NCT ID:** NCT01270139
- **Lead sponsor:** Ural State Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04-01
- **Primary completion:** 2009-04-01
- **Final completion:** 2016-08-01
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2021-03-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01270139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01270139, "Plasmonic Nanophotothermal Therapy of Atherosclerosis". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT01270139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*